金石亚药跌2.04%，成交额5433.60万元，主力资金净流出745.08万元

Core Points - The stock price of Jinshi Asia Pharmaceutical has decreased by 2.04% on October 29, trading at 10.58 CNY per share with a market capitalization of 4.25 billion CNY [1] - The company has experienced a year-to-date stock price increase of 29.32%, but has seen a decline of 9.26% over the last five trading days [1] Financial Performance - For the period from January to September 2025, Jinshi Asia Pharmaceutical reported a revenue of 708 million CNY, a year-on-year decrease of 6.37%, while the net profit attributable to shareholders increased by 66.47% to 96.77 million CNY [2] - The company's main business revenue composition includes 82.76% from pharmaceutical sales, 14.09% from production line and related sales, and 3.16% from property leasing and management [2] Shareholder Information - As of September 30, the number of shareholders for Jinshi Asia Pharmaceutical is 23,200, an increase of 1.72% from the previous period, with an average of 14,757 circulating shares per shareholder, a decrease of 1.69% [2] Dividend Distribution - Since its A-share listing, Jinshi Asia Pharmaceutical has distributed a total of 170 million CNY in dividends, with 71.91 million CNY distributed over the past three years [3]